A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
PHASE2CompletedINTERVENTIONAL
Enrollment
25
Participants
Timeline
Start Date
May 18, 2001
Primary Completion Date
April 27, 2004
Study Completion Date
April 27, 2004
Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG
Filgrastim SD/01
DRUG
Paclitaxel
DRUG
Topotecan
Trial Locations (1)
77030
UT MD Anderson Cancer Center, Houston
All Listed Sponsors
lead
M.D. Anderson Cancer Center
OTHER
NCT00038545 - A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter